Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111433 Target Snapshot

Muscarinic receptor M1 and M2 · SELECTIVITY GROUP · Rattus norvegicus

156Compounds
11Assays
1Approved Drugs
25.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P08482. Use UniProt P08482 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P08482 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Muscarinic receptor M1 and M2 as ChEMBL target CHEMBL2111433, mapped to UniProt P08482. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Muscarinic receptor M1 and M2
SELECTIVITY GROUP · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2111433
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P08482
Muscarinic acetylcholine receptor M1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Muscarinic receptor M1 and M2 is the right protein anchor across sources, using UniProt P08482 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMuscarinic acetylcholine receptor M1
UniProt AccessionP08482
Component TypeProtein
Sequence Length460 aa

Muscarinic acetylcholine receptor M1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Muscarinic receptor M1 and M2, mapped to UniProt P08482. ChEMBL maps the protein component as Muscarinic acetylcholine receptor M1. Sequence length is 460 aa.

Mapped IDP08482
Review nameMuscarinic receptor M1 and M2
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5025.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL167438 7.5 IC50 32.0 Preclinical
CHEMBL314737 7.06 IC50 88.0 Preclinical
CHEMBL83074 6.02 IC50 958.0 Preclinical
CHEMBL354259 5.94 IC50 1156.0 Preclinical
CHEMBL166423 5.69 IC50 2030.0 Preclinical
CHEMBL168561 5.54 IC50 2914.0 Preclinical
CHEMBL352908 5.51 IC50 3112.0 Preclinical
CHEMBL166593 5.45 IC50 3540.0 Preclinical
CHEMBL167015 5.44 IC50 3655.0 Preclinical
CHEMBL166537 5.4 IC50 3984.0 Preclinical
Distribution

pChEMBL Value Distribution

13
5.0
4
5.5
1
6.0
0
6.5
1
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

11
Total Assays
24
Tested Compounds
2
Assay Types
Binding — 9 assays, 24 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 24 5.4
protein format 4 0
Functional — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine